Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease

Despite the curative potential of hematopoietic cell transplantation (HCT) for hematologic malignancies, graft-versus-host disease (GVHD) remains a substantial cause of morbidity and mortality, particularly if treatment is refractory. Treatment with additional immunosuppression including steroids of...

Descripción completa

Detalles Bibliográficos
Autores principales: Stenger, Elizabeth, Giver, Cynthia R., Langston, Amelia, Kota, Daniel, Das, Pankoj Kumar, Chinnadurai, Raghavan, Galipeau, Jacques, Waller, Edmund K., Qayed, Muna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515357/
https://www.ncbi.nlm.nih.gov/pubmed/36189324
http://dx.doi.org/10.3389/fimmu.2022.959658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515357/
https://www.ncbi.nlm.nih.gov/pubmed/36189324
http://dx.doi.org/10.3389/fimmu.2022.959658

Ejemplares similares